• Baicalin Methyl Ester and Intestinal Barrier Repair

  2026-09-08

  A 2024 Biomedicine & Pharmacotherapy study shows that baicalin methyl ester attenuates LPS-induced intestinal barrier injury in mice and MODE-K epithelial cells. Its central contribution is the integration of P65 binding evidence with TNF-α, MLCK, and tight-junction measurements, linking inflammatory signaling to barrier restoration.

• hiPSC Intestinal Organoids for Pharmacokinetics

  2026-09-08

  The 2025 study establishes a more accessible route for generating expandable, cryopreservable intestinal organoids from human induced pluripotent stem cells. Its differentiated monolayers contain intestinal epithelial cell types, including enterocytes with cytochrome P450 and transporter activities, making the platform relevant to human pharmacokinetic studies while still requiring enzyme-specific validation.

• Carbapenemase Gene Transmission in CREC

  2026-09-07

  A 2025 BMC Microbiology study mapped carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals, combining gene localization, conjugation, mobile-element analysis, and strain typing. Its findings show that blaNDM-1 was frequently plasmid-associated and readily transferable in vitro, highlighting the need to interpret resistance surveillance through both clonal and horizontal-transmission frameworks.

• Cefoperazone Sodium Salt: Research Workflows

  2026-09-07

  Cefoperazone sodium salt supports reproducible susceptibility testing, β-lactamase-resistance studies, and PK-informed biliary tract infection research. This guide translates comparative microbiology into practical formulation, assay-design, and troubleshooting decisions.

• Metabolomics Reveals Carbapenemase Resistance

  2026-09-05

  The reference study shows that LC-MS/MS metabolomics can distinguish carbapenemase-producing Enterobacterales from non-CPE isolates using a 21-metabolite biomarker panel. Its antibiotic-free workflow links resistant phenotypes to altered metabolic pathways and provides a foundation for faster, mechanism-informed diagnostics in antibiotic resistance studies.

• EphA2 Synthetic Lethality in MYC-Driven TNBC

  2026-09-04

  Ye and colleagues used a chemogenetic screen of approximately 600 kinase inhibitors to identify EphA2 inhibition as a selective vulnerability in MYC-driven triple-negative breast cancer. The lead compound ALW-II-41-27 induced intrinsic apoptosis in MYC-activated models, including p53-deficient contexts, and reduced tumor growth in two TNBC xenograft models without apparent toxicity.

• Piroxicam and Deracoxib in Canine Mammary Cancer Cells

  2026-09-04

  The reference study shows that piroxicam and deracoxib reduce viability and increase apoptosis in the CMT-U27 canine mammary carcinoma cell line, with combined treatment producing stronger effects at lower concentrations. Its value is primarily methodological and hypothesis-generating: MTT viability testing combined with flow-cytometric apoptosis and cell-cycle analysis provides a structured way to evaluate NSAID combinations without treating in vitro cytotoxicity as clinical efficacy.

• Sodium Overload and Mitochondrial Failure in NECSO

  2026-09-03

  The reference study identifies mitochondrial energy failure as the central mechanism linking TRPM4-mediated sodium influx to necrosis by sodium overload. Its findings connect mitochondrial Na+ and Ca2+ imbalance with impaired oxidative phosphorylation, ATP depletion, Na/K-ATPase failure, cell swelling, and lysis, providing a framework for interpreting sodium-driven cell injury assays.

• MAPK10–KRT16 Signaling in NSCLC Metastasis

  2026-09-03

  The reference study identifies MAPK10 as a metastasis-suppressing kinase that phosphorylates KRT16 at Ser356 and Ser397, enabling RNF213-dependent ubiquitination and proteasomal degradation. Cellular, animal, and clinical data support the MAPK10/KRT16/RNF213 axis as a mechanistic model and a candidate prognostic pathway in non-small cell lung cancer.

• Polygodial Workflows for TRPA1 Research

  2026-09-02

  Polygodial offers a chemically defined way to activate TRPA1 in calcium-imaging, sensory-neuron, and epithelial signaling experiments. This guide connects acute ion-channel measurements with Ca2+/NFAT-dependent inflammatory readouts while emphasizing practical dosing, controls, storage, and troubleshooting.

• Dibutyryl-cAMP: A Better Assay Control Strategy

  2026-09-02

  Dibutyryl-cAMP, sodium salt is more than a cAMP pathway agonist: it is a practical perturbation control for separating PKA signaling from tissue-specific biology. This article connects DBcAMP sodium salt workflow design with new lessons from tau research.

• Ceftazidime in the Resistance Translation Era

  2026-09-01

  Ceftazidime remains a strategically useful third-generation cephalosporin for Gram-negative bacterial infection research, particularly when Pseudomonas biology, β-lactamase activity, and resistance transmission must be interpreted together. This article connects its cell-wall mechanism with recent carbapenemase surveillance and provides practical guidance for translational assay design.

• Cy5 Maleimide in Condensate Imaging

  2026-09-01

  Cy5 maleimide enables site-specific protein labeling, but its value extends beyond conventional imaging. This article explains how non-sulfonated Cy5 maleimide can support charge-aware studies of α-synuclein condensates and improve interpretation of fluorescence partitioning assays.

• Penicillin G Sodium in Cell Culture Workflows

  2026-08-31

  Penicillin G Sodium provides targeted protection against susceptible bacterial contaminants while preserving the interpretability of mammalian cell assays when used with appropriate controls. This guide translates a melanoma-cell workflow into practical preparation, optimization, troubleshooting, and infection-research decisions.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-31

  A 2025 study found that naturally occurring angiotensin peptides can enhance SARS-CoV-2 spike-protein binding to host receptors, with particularly strong effects for shorter or N-terminally modified fragments. The work connects renin-angiotensin system peptide processing with a biochemical step relevant to viral entry, while its antibody-based design indicates that validation in cellular and physiological models is still needed.

7963 records 2/531 page Previous Next 12345 下5页 Last page